Published in Cancer Weekly, February 5th, 2002
Little is known about early childhood central nervous system tumors. Their diagnosis, on the basis of appearance alone, is controversial and patients' response to therapy has to date been difficult to predict.
So Todd R. Golub of the Massachusetts Institute of Technology, Cambridge, Massachusetts, and colleagues have developed a classification system based on DNA microarray gene expression data that demonstrates that medulloblastomas are molecularly distinct from other tumors. This data also helps shed some...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.